Milestone Pharmaceuticals Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Milestone Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.62M, a 37.4% increase year-over-year.
  • Milestone Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$43.6M, a 28.7% increase year-over-year.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$61.1M, a 2.44% decline from 2022.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$59.6M, a 38.5% decline from 2021.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$43.1M, a 15.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.